Warning letter
Integrated Health Concepts Inc. dba Conversio Health: warning letter of Sep 10, 2020
FDA warning letter 610546 · Division of Pharmaceutical Quality Operations IV
Key facts
| Reference number | 610546 |
|---|---|
| Company | Integrated Health Concepts Inc. dba Conversio Health |
| Subject | Compounding Pharmacy/Adulterated Drug Products |
| Issue date | Sep 10, 2020 |
| Posted date | Sep 22, 2020 |
| Issuing office | Division of Pharmaceutical Quality Operations IV |
| Product type | Drugs |
| Inspection city | San Luis Obispo |
| Inspection ZIP | 93401 |
| Inspection start date | Aug 13, 2019 |
| Letter on fda.gov | fda.gov |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: